Helix BioMedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Helix BioMedix Inc (Helix) is a dermatology and consumer skin care products company. It develops an extensive proprietary library of structurally diverse bioactive peptides for the applications in consumer skin care products and prescription products. Its peptides are used in cosmeceuticals, anti-aging skin care products, acne treatment, wound healing and other topical anti-infective treatments. The company is also developing drug candidate peptides for acne, methicillin-resistant staphylococcus aureus (MRSA) and other dermatological conditions. Helix is partnered with contract research organizations, fine ingredient suppliers and manufacturers. The company offers its cosmeceutical active ingredient through its distribution partners. Helix is headquartered in Bothell, Washington, the US.

Helix BioMedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Helix BioMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Helix Biomedix Completes Private Placement Of Shares For US$0.5 Million 10
Helix BioMedix Completes Private Placement Of US$0.6 Million 11
Helix BioMedix Completes Private Placement Of US$5.98 Million 12
Helix BioMedix Inc - Key Competitors 13
Helix BioMedix Inc - Key Employees 14
Helix BioMedix Inc - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Jul 24, 2017: EverlyWell Partners with Helix to Launch New Suite of DNA Tests to Provide Deeper Insights about Health and Wellness 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables

List of Tables
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Helix BioMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Helix BioMedix Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Helix Biomedix Completes Private Placement Of Shares For US$0.5 Million 10
Helix BioMedix Completes Private Placement Of US$0.6 Million 11
Helix BioMedix Completes Private Placement Of US$5.98 Million 12
Helix BioMedix Inc, Key Competitors 13
Helix BioMedix Inc, Key Employees 14

Forkhead Box Protein M1 (Hepatocyte Nuclear Factor 3 Forkhead Homolog 11 or M Phase Phosphoprotein 2 or MPM 2 Reactive Phosphoprotein 2 or Transcription Factor Trident or Forkhead Related Protein FKHL16 or Winged Helix Factor From INS 1 Cells or FOXM1) - Drugs in Development, 2021

Forkhead Box Protein M1 (Hepatocyte Nuclear Factor 3 Forkhead Homolog 11 or M Phase Phosphoprotein 2 or MPM 2 Reactive Phosphoprotein 2 or Transcription Factor Trident or Forkhead Related Protein

USD 3000 View Report

Helix BioMedix Inc - Strategic SWOT Analysis Review

Helix BioMedix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available